{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:13:53Z","timestamp":1793747633269,"version":"4.6.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.123012","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:32:30Z","timestamp":1724445150000},"page":"123012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical applications of phosphocreatine and related mechanisms"],"prefix":"10.1016","volume":"355","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123012_bb0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/nu13041215","article-title":"Role of creatine in the heart: health and disease","volume":"13","author":"Balestrino","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2024.123012_bb0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0011-393X(05)80663-0","article-title":"Phosphocreatine: molecular and cellular aspects of the mechanism of cardioprotective action","volume":"53","author":"Saks","year":"1993","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.lfs.2024.123012_bb0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1113\/jphysiol.2001.012858","article-title":"The role of phosphorylcreatine and creatine in the regulation of mitochondrial respiration in human skeletal muscle","volume":"537","author":"Walsh","year":"2001","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2024.123012_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1155\/2002\/278437","article-title":"Muscle oxygenation and ATP turnover when blood flow is impaired by vascular disease","volume":"16","author":"Kemp","year":"2002","journal-title":"Spectroscopy"},{"key":"10.1016\/j.lfs.2024.123012_bb0025","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00726-011-0854-x","article-title":"Systems bioenergetics of creatine kinase networks: physiological roles of creatine and phosphocreatine in regulation of cardiac cell function","volume":"40","author":"Guzun","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.lfs.2024.123012_bb0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-5223(19)36192-6","article-title":"Protection of ischemic myocardium by exogenous phosphocreatine","volume":"94","author":"Semenovsky","year":"1987","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lfs.2024.123012_bb0035","unstructured":"Sharov VG, Afonskaya NI, Ruda MY, et al Protection of lschemic Myocardium by Exogenous Phosphocreatine (Neoton): Pharmacokinetics of Phosphocreatine, Reduction of Infarct Size, Stabilization of Sarcolemma of lschemic Cardiomyocytes, and Antithrombotic Action. 14."},{"key":"10.1016\/j.lfs.2024.123012_bb0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jamcollsurg.2003.05.001","article-title":"Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization","volume":"197","author":"Prabhakar","year":"2003","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.lfs.2024.123012_bb0045","article-title":"Protection of pancreatic \u03b2-cell by phosphocreatine through mitochondrial improvement via the regulation of dual AKT\/IRS-1\/GSK-3\u03b2 and STAT3\/Cyp-D signaling pathways","author":"Wang","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.lfs.2024.123012_bb0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0011-393X(05)80478-3","article-title":"Multicenter controlled study of creatine phosphate in the treatment of heart failure","volume":"52","author":"Grazioli","year":"1992","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.lfs.2024.123012_bb0055","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0002-8703(90)90124-G","article-title":"Electrophysiologic effects of exogenous phosphocreatine in cardiac tissue: potential antiarrhythmic actions","volume":"120","author":"Rosenshtraukh","year":"1990","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2024.123012_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0022-5223(19)37413-6","article-title":"Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia","volume":"87","author":"Robinson","year":"1984","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lfs.2024.123012_bb0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0011-393X(96)80065-8","article-title":"The effects of creatine phosphate in experimental myocardial infarction","volume":"57","author":"Mastroroberto","year":"1996","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.lfs.2024.123012_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1021576006103","article-title":"Cardioprotective effect of energostim during occlusion of coronary artery","volume":"134","author":"Karsanov","year":"2002","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02191530","article-title":"Participation of calcium ions in the molecular mechanism of cardioprotective action of exogenous phosphocreatine","volume":"86","author":"Konorev","year":"1991","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.123012_bb0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0002-8703(90)90124-G","article-title":"Electrophysiologic effects of exogenous phosphocreatine in cardiac tissue: potential antiarrhythmic actions","volume":"120","author":"Rosenshtraukh","year":"1990","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2024.123012_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10495-015-1210-5","article-title":"Phosphocreatine protects against LPS-induced human umbilical vein endothelial cell apoptosis by regulating mitochondrial oxidative phosphorylation","volume":"21","author":"Sun","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.lfs.2024.123012_bb0090","first-page":"26","article-title":"Phosphocreatine protects endothelial cells from methylglyoxal induced oxidative stress and apoptosis via the regulation of PI3K\/Akt\/eNOS and NF-\u03baB pathway","volume":"91","author":"Chu","year":"2017","journal-title":"VasculPharmacol"},{"key":"10.1016\/j.lfs.2024.123012_bb0095","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10495-015-1175-4","article-title":"Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K\/Akt\/eNOS pathway","volume":"20","author":"Ahsan","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.lfs.2024.123012_bb0100","first-page":"1","article-title":"Phosphocreatine preconditioning attenuates apoptosis in ischemia-reperfusion injury of rat brain","volume":"2011","author":"Tang","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.lfs.2024.123012_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117248","article-title":"Protection of diabetes-induced kidney injury by phosphocreatine via the regulation of ERK\/Nrf2\/HO-1 signaling pathway","volume":"242","author":"Shopit","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2024.123012_bb0110","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/01.CIR.0000072789.89096.10","article-title":"Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes","volume":"107","author":"Scheuermann-Freestone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123012_bb0115","doi-asserted-by":"crossref","first-page":"E229","DOI":"10.1152\/ajpendo.00426.2017","article-title":"Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study","volume":"315","author":"Ripley","year":"2018","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123012_bb0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbrc.2018.10.122","article-title":"Phosphocreatine attenuates endoplasmic reticulum stress-mediated hepatocellular apoptosis ameliorates insulin resistance in diabetes model","volume":"506","author":"Jamalat","year":"2018","journal-title":"BiochemBiophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123012_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111839","article-title":"Non-energy mechanism of phosphocreatine on the protection of cell survival","volume":"141","author":"Liu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.123012_bb0130","first-page":"1","article-title":"Phosphocreatine attenuates isoproterenol-induced cardiac fibrosis and cardiomyocyte apoptosis","volume":"2019","author":"Dai","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.lfs.2024.123012_bb0135","first-page":"2726","article-title":"Phosphocreatine attenuates angiotensin II-induced cardiac fibrosis in rat cardiomyocytes through modulation of MAPK and NF-\u03baB pathway","volume":"20","author":"Fei","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.123012_bb0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2018.03.014","article-title":"Neuroprotective effect of phosphocreatine on oxidative stress and mitochondrial dysfunction induced apoptosis in vitro and in vivo: involvement of dual PI3K\/Akt and Nrf2\/HO-1 pathways","volume":"120","author":"Li","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6521218","article-title":"Phosphocreatine improves cardiac dysfunction by normalizing mitochondrial respiratory function through JAK2\/STAT3 signaling pathway in vivo and in vitro","volume":"2019","author":"Qaed","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2024.123012_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0006-2944(78)90017-0","article-title":"Studies of energy transport in heart cells","volume":"19","author":"Rosenshtraukh","year":"1978","journal-title":"Biochem. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2024.123012_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414554945","article-title":"Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson\u2019s model","volume":"6","author":"Cunha","year":"2014","journal-title":"ASN Neuro"},{"key":"10.1016\/j.lfs.2024.123012_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.freeradbiomed.2020.10.003","article-title":"The neuroprotective effects of phosphocreatine on amyloid beta 25\u201335-induced differentiated neuronal cell death through inhibition of AKT\/GSK-3\u03b2\/Tau\/APP\/CDK5 pathways in vivo and vitro","volume":"162","author":"Ai","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0170","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (review)","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","article-title":"Epidermal growth factor receptor transactivation: mechanisms, pathophysiology, and potential therapies in the cardiovascular system","volume":"56","author":"Forrester","year":"2016","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2024.123012_bb0180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2024.123012_bb0185","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00454.2014","article-title":"Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-\u03b2\/Smad3 pathway","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2024.123012_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10120-022-01340-7","article-title":"Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK\/JUN\/HK2 axis regulated glycolysis","volume":"26","author":"Mi","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.lfs.2024.123012_bb0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"WIREs Syst. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0200","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/antiox9070626","article-title":"Erythronium japonicum alleviates inflammatory pain by inhibiting MAPK activation and by suppressing NF-\u03baB activation via ERK\/Nrf2\/HO-1 signaling pathway","volume":"9","author":"Park","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2024.123012_bb0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.yjmcc.2015.10.010","article-title":"Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-\u03baB signaling activation in the heart","volume":"89","author":"Cong","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2024.123012_bb0210","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/21218","article-title":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt","volume":"399","author":"Fulton","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123012_bb0215","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.celrep.2018.02.049","article-title":"PI3K\/Akt cooperates with oncogenic notch by inducing nitric oxide-dependent inflammation","volume":"22","author":"Villegas","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2024.123012_bb0220","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/01.CIR.103.16.2102","article-title":"Oxidized LDL inhibits vascular endothelial growth factor\u2013induced endothelial cell migration by an inhibitory effect on the Akt\/endothelial nitric oxide synthase pathway","volume":"103","author":"Chavakis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123012_bb0225","series-title":"Oxidant Stress-induced Loss of IRS-1 and IRS-2 Proteins in Rat Skeletal Muscle: Role of p38 MAPK","volume":"8","author":"Archuleta","year":"2009"},{"key":"10.1016\/j.lfs.2024.123012_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113690","article-title":"The bidirectional role of the JAK2\/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury","volume":"341","author":"Zhong","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2024.123012_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8891373","article-title":"Albumin reduces oxidative stress and neuronal apoptosis via the ERK\/Nrf2\/HO-1 pathway after intracerebral hemorrhage in rats","volume":"2021","author":"Deng","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2024.123012_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105033","article-title":"Pharmacokinetics and hemorheology of phosphocreatine and creatine in rabbits: a directly comparative study between parent drug and active metabolite","volume":"138","author":"Xi","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.123012_bb0245","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/icvts\/ivw171","article-title":"Cardiac protection with phosphocreatine: a meta-analysis","volume":"23","author":"Landoni","year":"2016","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.lfs.2024.123012_bb0250","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.hlc.2016.12.020","article-title":"Creatine phosphate administration in cell energy impairment conditions: a summary of past and present research","volume":"26","author":"Gaddi","year":"2017","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.lfs.2024.123012_bb0255","doi-asserted-by":"crossref","first-page":"089","DOI":"10.31083\/j.rcm2303089","article-title":"Protection of exogenous phosphocreatine for myocardium in percutaneous coronary intervention related to inflammation","volume":"23","author":"Ling","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0003319713515996","article-title":"The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention","volume":"66","author":"Ke-Wu","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.lfs.2024.123012_bb0265","first-page":"1","article-title":"The protective effect of Cx43 protein-mediated phosphocreatine on myocardial ischemia\/reperfusion injury","volume":"2021","author":"Wang","year":"2021","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.lfs.2024.123012_bb0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12017-008-8053-y","article-title":"Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases","volume":"10","author":"Adhihetty","year":"2008","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.lfs.2024.123012_bb0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brainresbull.2008.02.035","article-title":"Functions and effects of creatine in the central nervous system","volume":"76","author":"Andres","year":"2008","journal-title":"Brain Res. Bull."},{"issue":"S16","key":"10.1016\/j.lfs.2024.123012_bb0280","article-title":"Cardiac protection with phosphocreatine: a meta-analysis","volume":"30","author":"Fominskiy","year":"2016","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.lfs.2024.123012_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005184.pub2","article-title":"Creatine and creatine analogues in hypertension and cardiovascular disease","author":"Horjus","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2024.123012_bb0290","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/1053-0770(91)90122-A","article-title":"Biochemical changes induced in the myocardial cell during cardioplegic arrest supplemented with creatine phosphate","volume":"5","author":"Pastoris","year":"1991","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.lfs.2024.123012_bb0295","article-title":"Simultaneous quantitative analysis of phosphocreatine, creatine and creatinine in plasma of children by HPLC\u2013MS\/MS method: application to a pharmacokinetic study in children with viral myocarditis","volume":"e4558","author":"Sun","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.lfs.2024.123012_bb0300","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00726-016-2173-8","article-title":"Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease","volume":"48","author":"Balestrino","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.lfs.2024.123012_bb0305","doi-asserted-by":"crossref","DOI":"10.1053\/j.jvca.2020.09.055","article-title":"Prophylaxis postoperative atrial fibrillation (POAF) with exogenous phosphocreatine in cardiac surgery","volume":"34","author":"Aliev","year":"2020","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.lfs.2024.123012_bb0310","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0011-393X(05)80050-5","article-title":"Effect of exogenous phosphocreatine on endothelium and endothelium-dependent vascular reactions in immune cardiac injury","volume":"52","author":"Moibenko","year":"1992","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.lfs.2024.123012_bb0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MCA.0b013e32835aab95","article-title":"Role of creatine phosphate as a myoprotective agent during coronary artery bypass graft in elderly patients","volume":"24","author":"Guo-han","year":"2013","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.lfs.2024.123012_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152881","article-title":"Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro","volume":"460","author":"Wang","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2024.123012_bb0325","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00795-017-0176-5","article-title":"Creatine phosphate disodium salt protects against Dox-induced cardiotoxicity by increasing calumenin","volume":"51","author":"Wang","year":"2018","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.lfs.2024.123012_bb0330","series-title":"Effect of Creatine Phosphate Sodium on miRNA378, miRNA378* and Calumenin mRNA in Adriamycin-Injured Cardiomyocytes","volume":"5","author":"Yu","year":"2016"},{"key":"10.1016\/j.lfs.2024.123012_bb0335","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3892\/mmr.2014.2219","article-title":"Cardioprotective effects of phosphocreatine on myocardial cell ultrastructure and calcium-sensing receptor expression in the acute period following high level spinal cord injury","volume":"10","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2024.123012_bb0340","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420950583","article-title":"Effect of norepinephrine combined with sodium phosphocreatine on cardiac function and prognosis of patients with septic shock","volume":"34","author":"Kang","year":"2020","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123012_bb0345","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/0300060517744957","article-title":"Effect of creatine phosphate sodium on bispectral index and recovery quality during the general anaesthesia emergence period in elderly patients: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Wang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.lfs.2024.123012_bb0350","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2147\/DDDT.S203564","article-title":"Phosphocreatine attenuates Gynura segetum-induced hepatocyte apoptosis via a SIRT3-SOD2-mitochondrial reactive oxygen species pathway","volume":"13","author":"Li","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2024.123012_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043178","article-title":"Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects","volume":"7","author":"Tokarska-Schlattner","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.123012_bb0360","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-2828(89)91494-6","article-title":"Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate","volume":"21","author":"Zucchi","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2024.123012_bb0365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5847\/wjem.j.1920-8642.2011.04.009","article-title":"Effect of exogenous phosphocreatine on cardiomycytic apoptosis and expression of Bcl-2 and Bax after cardiopulmonary resuscitation in rats","volume":"2","author":"Yan","year":"2011","journal-title":"World J Emerg Med"},{"key":"10.1016\/j.lfs.2024.123012_bb0370","first-page":"8659","article-title":"Therapeutic effect of captopril combined with phosphocreatine sodium on viral myocarditis","volume":"14","author":"Wang","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2024.123012_bb0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00431-015-2601-x","article-title":"Beneficial effects of creatine phosphate sodium for the treatment of Henoch\u2013Sch\u00f6nlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels","volume":"175","author":"Zhang","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.lfs.2024.123012_bb0380","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tcb.2021.11.004","article-title":"The two sides of creatine in cancer","volume":"32","author":"Zhang","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.lfs.2024.123012_bb0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s42255-019-0159-z","article-title":"The creatine\u2013phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis","volume":"2","author":"Papalazarou","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.lfs.2024.123012_bb0390","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2014.12.018","article-title":"Extracellular metabolic energetics can promote cancer progression","volume":"160","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.123012_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108566","article-title":"Suppression of the KRAS-NRF2 axis shifts arginine into the phosphocreatine energy system in pancreatic cancer cells","volume":"26","author":"Di Giorgio","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.lfs.2024.123012_bb0400","doi-asserted-by":"crossref","first-page":"1176956","DOI":"10.3389\/fimmu.2023.1176956","article-title":"Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123012_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117248","article-title":"Protection of diabetes-induced kidney injury by phosphocreatine via the regulation of ERK\/Nrf2\/HO-1 signaling pathway","volume":"242","author":"Shopit","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2024.123012_bb0410","first-page":"1","article-title":"Neuroprotective effect of phosphocreatine on focal cerebral ischemia-reperfusion injury","volume":"2012","author":"Li","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.lfs.2024.123012_bb0415","first-page":"3432","article-title":"Serum metabolomic analysis revealed potential metabolite biomarkers for diabetes mellitus with coronary heart disease","volume":"15","author":"Jin","year":"2023","journal-title":"Anal. Methods Adv. Methods Appl."},{"key":"10.1016\/j.lfs.2024.123012_bb0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12031-023-02175-2","article-title":"Uncovering the therapeutic potential of phosphocreatine in diabetic retinopathy: mitigating mitochondrial dysfunction and apoptosis via JAK2\/STAT3 signaling pathway","volume":"74","author":"Qaed","year":"2024","journal-title":"J. Mol. Neurosci. MN"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524006027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524006027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T01:30:00Z","timestamp":1725931800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524006027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":84,"alternative-id":["S0024320524006027"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123012","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical applications of phosphocreatine and related mechanisms","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123012"}}